Artículos por temáticas

Statin use and risk of dementia or Alzheimer's disease: a systematic review and meta-analysis of observational studies

Olmastroni E, Molari G, De Beni N, Colpani O, Galimberti F, Gazzotti M, Zambon A, Catapano AL, Casula M.

Eur J Prev Cardiol. 2022 May 5;29(5):804-814. doi: 10.1093/eurjpc/zwab208.

Effect of a Vegan Diet on Alzheimer's Disease

Katonova A, Sheardova K, Amlerova J, Angelucci F, Hort J.

Int J Mol Sci. 2022 Nov 29;23(23):14924. doi: 10.3390/ijms232314924.

Role of Cholinergic Signaling in Alzheimer's Disease

Chen ZR, Huang JB, Yang SL, Hong FF.

Molecules. 2022 Mar 10;27(6):1816. doi: 10.3390/molecules27061816.

Microglia in the Neuroinflammatory Pathogenesis of Alzheimer's Disease and Related Therapeutic Targets

Cai Y, Liu J, Wang B, Sun M, Yang H.

Front Immunol. 2022 Apr 26;13:856376. doi: 10.3389/fimmu.2022.856376. eCollection 2022.

Alzheimer Disease

McDade EM.

Continuum (Minneap Minn). 2022 Jun 1;28(3):648-675. doi: 10.1212/CON.0000000000001131.

Cortical excitability and plasticity in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis of transcranial magnetic stimulation studies

Chou YH, Sundman M, Ton That V, Green J, Trapani C.

Ageing Res Rev. 2022 Aug;79:101660. doi: 10.1016/j.arr.2022.101660. Epub 2022 Jun 6.

The Effect of Aerobic Exercise on Cognitive Function in People with Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Zhang S, Zhen K, Su Q, Chen Y, Lv Y, Yu L.

Int J Environ Res Public Health. 2022 Nov 25;19(23):15700. doi: 10.3390/ijerph192315700.

Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study

McDade E, Cummings JL, Dhadda S, Swanson CJ, Reyderman L, Kanekiyo M, Koyama A, Irizarry M, Kramer LD, Bateman RJ.

Alzheimers Res Ther. 2022 Dec 21;14(1):191. doi: 10.1186/s13195-022-01124-2.

Mediterranean diet adherence, gut microbiota, and Alzheimer's or Parkinson's disease risk: A systematic review

Solch RJ, Aigbogun JO, Voyiadjis AG, Talkington GM, Darensbourg RM, O'Connell S, Pickett KM, Perez SR, Maraganore DM.

J Neurol Sci. 2022 Mar 15;434:120166. doi: 10.1016/j.jns.2022.120166. Epub 2022 Jan 26.

Challenges and hopes for Alzheimer's disease

Tatulian SA.

Drug Discov Today. 2022 Apr;27(4):1027-1043. doi: 10.1016/j.drudis.2022.01.016. Epub 2022 Feb 1.

Brain-derived neurotrophic factor in Alzheimer's disease and its pharmaceutical potential

Gao L, Zhang Y, Sterling K, Song W.

Transl Neurodegener. 2022 Jan 28;11(1):4. doi: 10.1186/s40035-022-00279-0.

The future of stem cell therapies of Alzheimer's disease

Wang ZB, Wang ZT, Sun Y, Tan L, Yu JT.

Ageing Res Rev. 2022 Sep;80:101655. doi: 10.1016/j.arr.2022.101655. Epub 2022 Jun 2.

Precision Medicine Approach to Alzheimer's Disease: Successful Pilot Project

Toups K, Hathaway A, Gordon D, Chung H, Raji C, Boyd A, Hill BD, Hausman-Cohen S, Attarha M, Chwa WJ, Jarrett M, Bredesen DE.

J Alzheimers Dis. 2022;88(4):1411-1421. doi: 10.3233/JAD-215707.

Signal pathways in the treatment of Alzheimer's disease with traditional Chinese medicine

Ding MR, Qu YJ, Hu B, An HM.

Biomed Pharmacother. 2022 Aug;152:113208. doi: 10.1016/j.biopha.2022.113208. Epub 2022 May 31.

The glymphatic system: implications for drugs for central nervous system diseases

Lohela TJ, Lilius TO, Nedergaard M.

Nat Rev Drug Discov. 2022 Oct;21(10):763-779. doi: 10.1038/s41573-022-00500-9. Epub 2022 Aug 10.